Results 191 to 200 of about 252,843 (247)
Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry. [PDF]
Trewin-Nybråten CB +16 more
europepmc +1 more source
AI‐Driven Microphysiological Systems for Advancing Nanoparticle Therapeutics
This review outlines recent advances in integrating artificial intelligence with microphysiological systems for nanoparticle evaluation. It highlights data‐driven optimization, image‐based prediction, and AI‐enabled analysis frameworks that advance translational research and support the development of personalized nanomedicine. Nanoparticles (NPs) play
Yedam Lee +3 more
wiley +1 more source
Age is not a significant predictor of survival in patients with IDH-wildtype glioblastoma that undergo gross total resection and complete adjuvant chemoradiation. [PDF]
Cozzens JW +14 more
europepmc +1 more source
Abstract Background Intracerebral hemorrhage (ICH) remains a devastating neurological disorder with limited therapeutic options. Neural stem cell (NSC)‐based therapies have emerged as a potential regenerative approach, yet the molecular mechanisms regulating NSC behavior require further elucidation.
Wei Dai +7 more
wiley +1 more source
How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype. [PDF]
Roux A, Elia A, Zanello M, Pallud J.
europepmc +1 more source
A 6½‐year‐old girl was diagnosed with a medulloblastoma, SHH activated, subtype 3 and TP53 mutant (somatic). After surgery and chemotherapy, she was monitored with quarterly magnetic resonance imaging (MRI) scans and remained free of disease for almost 4 years.
Daniel Antunes Moreno +19 more
wiley +1 more source
Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype. [PDF]
Pedersen V +4 more
europepmc +1 more source

